Mebendazole was given to mice infected withAngiostrongyls costaricensis at a single dose of 5 mg/kg at 6, 11, 16 or 21 days post-infection (p.i.) and in five successive doses at 5 mg/kg daily at 6, 11 or 16 days p.i. The effects were comparatively assessed by examining various parameters in host mice and worms. As a whole, the effects of mebendazole were caused more conspicuously by five successive treatments than by a single treatment. In both treatment modalities, the effects were more remarkable in earlier treatments, and nearly complete effects were caused by five successive treatments before 15 days p.i. These results suggest that the inhibition of egg formation and/or oviposition will inhibit the pathological changes caused in the disease byA. costaricensis, especially before the onset of the changes.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Akyol CV, Kino H, Terada M, Sano M (1993) Effects of netobimin on systemic infection with larval nematodes in mice (in Japanese). Jpn J Parasitol 42:83–84
Eyle P (1970) Some pharmacodynamic effects of the nematocide: methyridine, tetramisole and pyrantel. J Pharm Pharmacol 22:26–36
Hayashi M (1987) Studies on chemotherapy of parasitic helminths. XXX. Clinical and pathological changes in mice infected withAngiostrongylus cantonensis and treatment with mebendazole and betamethasone. Jpn J Parasitol 36:80–87
Hayashi M, Terada M, Ishii AI, Kino H, Sano M (1982) Studies on chemotherapy of parasitic helminths. XIV. Anthelmintic effect of mebendazole onAngiostrongylus cantonensis in rats. Jpn J Parasitol 31:575–580
Hawking F (1979) Diethylcarbamazine and new compounds for the treatment of filariasis. Adv Pharmacol 16:129–194
Ishii AI, Terada M, Fujiu Y, Sano M (1989) In vivo efficacy of levamisole against larval stages ofAngiostrongylus cantonensis andA. costaricensis. Southeast Asian J Trop Med Public Health 20:109–117
Joubert J, Joubert MJ, Lombaard CM (1985) Neurocysticercosis — a comprehensive approach to medical treatment. S Afr Med J 68:11–14
Morera P (1985) Abdominal angiostrongyliasis: a problem of public health. Parasitol Today 1:173–175
Terada M, Sano M (1989) Protective resistance against resistance withAngiostrongylus costaricensis in mice treated with larvicidal anthelmintics after primary infection (in Japanese). Jpn J Parasitol 38:344–352
Terada M, Rodriguez BO, Dharejo AM, Ishii AI, Sano M (1986) Studies on chemotherapy of parasitic helminths. XXVI. Comparative in vitro effects of various anthelmintics on the motility ofAngiostrongylus costaricensis andA. cantonensis. Jpn J Parasitol 35:365–367
Terada M, Ishii AI, Dharejo AM, Hayashi M, Sano M (1987) Studies on chemotherapy of parasitic helminths. XXVII. In vivo efficacy of milbemycin D against larval stages ofAngiostrongylus cantonensis andA. costaricensis. Jpn J Parasitol 36:24–29
Terada M, Ishih A, Sano M (1991a) Studies on chemotherapy of parasitic helminths. XXXVI. Indicative changes for experimental chemotherapy in mice infected withAngiostrongylus costaricensis (in Japanese). Jpn J Parasitol 40:415–423
Terada M, Kino H, Sano M (1991b) Studies on chemotherapy of parasitic helminths. XXXVII. Growth ofAngiostrongylus costaricensis in ddY mice (in Japanese). Jpn J Parasitol 40:521–527
Terada M, Tungtrongchitr A, Ishih A, Sano M (1992) Effects of mebendazole on abdominal angiostrongyliasis in mice after worm maturation: preliminary trials. Jpn J Parasitol 41:481–486
Vanden Bossche H (1985) Pharmacology of anthelmintics. In: VandenBossche H, Thienpont F, Janssens PG (eds) Chemotherapy of gastro-intestinal helminths. Springer, Berlin Heidelberg New York Tokyo, pp 125–181
About this article
Cite this article
Terada, M., Kino, H., Akyol, C.V. et al. Effects of mebendazole onAngiostrongylus costaricensis in mice, with special reference to the timing of treatment. Parasitol Res 79, 441–443 (1993). https://doi.org/10.1007/BF00931579
- Single Dose
- Treatment Modality
- Early Treatment
- Successive Treatment
- Special Reference